Cognitive enhancers in the treatment of substance use disorders: clinical evidence
Attenuation of drug reward has been the major focus of medication development in the
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence
KT Brady, KM Gray, BK Tolliver - Pharmacology, Biochemistry and …, 2011 - infona.pl
Attenuation of drug reward has been the major focus of medication development in the
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
Cognitive enhancers in the treatment of substance use disorders: clinical evidence
KT Brady, KM Gray, BK Tolliver - Pharmacology …, 2011 - pubmed.ncbi.nlm.nih.gov
Attenuation of drug reward has been the major focus of medication development in the
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence.
KT Brady, KM Gray, BK Tolliver - Pharmacology, Biochemistry and …, 2011 - psycnet.apa.org
Attenuation of drug reward has been the major focus of medication development in the
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
addiction area to date. With the growth of research in the area of cognitive neuroscience, the …
[引用][C] Cognitive enhancers in the treatment of substance use disorders: Clinical evidence
KT BRADY, KM GRAY… - Pharmacology …, 2011 - pascal-francis.inist.fr
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[HTML][HTML] Cognitive Enhancers in the Treatment of Substance Use Disorders: Clinical Evidence
KT Brady, RH Johnson, KM Gray… - Pharmacology …, 2011 - ncbi.nlm.nih.gov
Attenuation of drug reward has been the major focus of medication development in the
addictions area to date. With the growth of research in the area of cognitive neuroscience …
addictions area to date. With the growth of research in the area of cognitive neuroscience …
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
KT Brady, KM Gray, BK Tolliver - Pharmacology, Biochemistry, and …, 2011 - europepmc.org
Attenuation of drug reward has been the major focus of medication development in the
addictions area to date. With the growth of research in the area of cognitive neuroscience …
addictions area to date. With the growth of research in the area of cognitive neuroscience …
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
KT Brady, KM Gray, BK Tolliver - Pharmacology, Biochemistry, and …, 2011 - europepmc.org
Attenuation of drug reward has been the major focus of medication development in the
addictions area to date. With the growth of research in the area of cognitive neuroscience …
addictions area to date. With the growth of research in the area of cognitive neuroscience …